简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Research
HOME
·
07588.HK
CSOP HANG SENG CHINA ENTERPRISES INDEX DAILY (-2X) INVERSE PRODUCT (07588.HK) Rises 1.80% Intraday at HK$1.468
Tags:
CSOP HANG SENG CHINA ENTERPRISES INDEX DAILY (-2X) INVERSE PRODUCT
07588.HK
ETF
2026-08-04
CSOP HANG SENG CHINA ENTERPRISES INDEX DAILY (-2X) INVERSE PRODUCT(07588.HK): Intraday Rise of 3.04%, Average Trading Price at HK$1.952
Tags:
CSOP HANG SENG CHINA ENTERPRISES INDEX DAILY (-2X) INVERSE PRODUCT
07588.HK
ETF
2026-06-30
CSOP HANG SENG CHINA ENTERPRISES INDEX DAILY (-2X) INVERSE PRODUCT(07588.HK) Falls 0.22% Intraday, NAV Per Unit at HK$1.848
Tags:
CSOP HANG SENG CHINA ENTERPRISES INDEX DAILY (-2X) INVERSE PRODUCT
07588.HK
ETF
2026-06-24
CSOP HANG SENG CHINA ENTERPRISES INDEX DAILY (-2X) INVERSE PRODUCT(07588.HK) Rises 2.34% Intraday at an Average Price of HK$1.664
Tags:
CSOP HANG SENG CHINA ENTERPRISES INDEX DAILY (-2X) INVERSE PRODUCT
07588.HK
ETF
2026-06-11
CSOP HANG SENG CHINA ENTERPRISES INDEX DAILY (-2X) INVERSE PRODUCT(07588.HK) Rises 3.6% Intraday, NAV at HK$1.583
Tags:
CSOP HANG SENG CHINA ENTERPRISES INDEX DAILY (-2X) INVERSE PRODUCT
07588.HK
ETF
2026-06-08
CSOP HANG SENG CHINA ENTERPRISES INDEX DAILY (-2X) INVERSE PRODUCT(07588.HK) rises 0.28%, intraday turnover rate at 2.52%
Tags:
CSOP HANG SENG CHINA ENTERPRISES INDEX DAILY (-2X) INVERSE PRODUCT
07588.HK
ETF
2026-05-11
Featured News
ETF
Premia FTSE TWSE Taiwan 50 ETF (03453.HK) Rises 1.80% in Early Trading at an Average Price of HK$162.85
ETF
CSOP HANG SENG CHINA ENTERPRISES INDEX DAILY (-2X) INVERSE PRODUCT (07588.HK) Rises 1.80% Intraday at HK$1.468
ETF
CSOP Hang Seng Biotech ETF (03174.HK) Rises 2.54% in Early Trading, NAV Per Unit at HK$3.304
ETF
Csop Samsung Electronics Daily (-2x) Inverse Product (07347.HK) Rises 2.67% in Early Morning Trading at an Average Price of HK$1.013
Finance
ALPHAMAB ONCOLOGY (09966.HK): Enters JSKN016 Licence Agreement with Pathos AI
Finance
CARsgen Therapeutics(02171.HK): CT0596 Secures NMPA IND Approval for Treatment of R/R MM
Finance
Jiangsu Guofu Hydrogen Energy Equipment (02582.HK): Completes H-share Full Circulation
Finance
Youzan Technology Limited (06051.HK): Expected First-Half Profit of RMB65 Million to RMB72 Million
Finance
Shaanxi Micot Pharmaceutical Technology (02335.HK): Phase II Trial of MT200605 for Acute Ischemic Stroke Meets Primary Endpoint
Finance
Xiabuxiabu (00520.HK): First-Half Loss Narrowed Significantly
Scan QR Code
Download App